Abstract
Epigenetic mechanisms might play a role in the pathophysiology of hypertension, a major risk factor for cardiovascular disease and renal failure. We aimed to systematically review studies investigating the association between epigenetic marks (global, candidate-gene or genome-wide methylation of DNA, and histone modifications) and blood pressure or hypertension. Five bibliographic databases were searched until the 7th of December 2018. Of 2984 identified references, 26 articles based on 25 unique studies met our inclusion criteria, which involved a total of 28,382 participants. The five studies that assessed global DNA methylation generally found lower methylation levels with higher systolic blood pressure, diastolic blood pressure, and/or presence of hypertension. Eighteen candidate-gene studies reported, in total, 16 differentially methylated genes, including renin–angiotensin-system-related genes (ACE promoter and AGTR1) and genes involved in sodium homeostasis and extracellular fluid volume maintenance system (NET promoter, SCNN1A, and ADD1). Between the three identified epigenome-wide association studies (EWAS), lower methylation levels of SULF1, EHMT2, and SKOR2 were found in hypertensive patients as compared with normotensive subjects, and lower methylation levels of PHGDH, SLC7A11, and TSPAN2 were associated with higher systolic and diastolic blood pressure. In summary, the most convincing evidence has been reported from candidate-gene studies, which show reproducible epigenetic changes in the interconnected renin–angiotensin and inflammatory systems. Our study highlights gaps in the literature on the role of histone modifications in blood pressure and the need to conduct high-quality studies, in particular, hypothesis-generating studies that may help to elucidate new molecular mechanisms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Change history
27 August 2019
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
References
Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, et al. Global burden of hypertension and systolic blood pressure of at Least 110 to 115 mmHg, 1990–2015. JAMA. 2017;317:165–82.
Collins R, Peto R, MacMahon S, Hebert P, Fiebach NH, Eberlein KA, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827–38.
Jiang S-Z, Lu W, Zong X-F, Ruan H-Y, Liu Y. Obesity and hypertension. Exp Ther Med. 2016;12:2395–9.
Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev. 2017;4:CD004022.
Diaz KM, Shimbo D. Physical activity and the prevention of hypertension. Curr Hypertens Rep. 2013;15:659–68.
Kupper N, Willemsen G, Riese H, Posthuma D, Boomsma DI, de Geus EJC. Heritability of daytime ambulatory blood pressure in an extended twin design. Hypertension. 2005;45:80–5.
Evangelou E, Warren HR, Mosen-Ansorena D, Mifsud B, Pazoki R, Gao H, et al. Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits. Nat Genet. 2018;50:1412.
Warren HR, Evangelou E, Cabrera CP, Gao H, Ren M, Mifsud B, et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet. 2017;49:403–15.
Wain LV, Vaez A, Jansen R, Joehanes R, van der Most PJ, Erzurumluoglu AM, et al. Novel blood pressure locus and gene discovery using genome-wide association study and expression data sets from blood and the kidney. Hypertension. 2017;70:e4–19.
Munroe PB, Barnes MR, Caulfield MJ. Advances in blood pressure genomics. Circ Res. 2013;112:1365–79.
Muka T, Koromani F, Portilla E, O’Connor A, Bramer WM, Troup J, et al. The role of epigenetic modifications in cardiovascular disease: a systematic review. Int J Cardiol. 2016;212:174–83.
Braun KV, Voortman T, Dhana K, Troup J, Bramer WM, Troup J, et al. The role of DNA methylation in dyslipidaemia: a systematic review. Prog Lipid Res. 2016;64:178–91.
Muka T, Nano J, Voortman T, Braun KVE, Ligthart S, Stranges S, et al. The role of global and regional DNA methylation and histone modifications in glycemic traits and type 2 diabetes: a systematic review. Nutr Metab Cardiovasc Dis. 2016;26:553–66.
Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–5.
Alexeeff SE, Baccarelli AA, Halonen J, Coull BA, Wright RO, Tarantini L, et al. Association between blood pressure and DNA methylation of retrotransposons and pro-inflammatory genes. Int J Epidemiol. 2013;42:270–80.
Bellavia A, Urch B, Speck M, Brook RD, Scott JA, Albetti B, et al. DNA hypomethylation, ambient particulate matter, and increased blood pressure: findings from controlled human exposure experiments. J Am Heart Assoc. 2013;2:1–10.
Kato N, Loh M, Takeuchi F, Verweij N, Wang X, Zhang W, et al. Trans-ancestry genome-wide association study identifies 12 genetic loci influencing blood pressure and implicates a role for DNA methylation. Nat Genet. 2015;47:1282–93.
European Society of Hypertension-European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011–53.
Turcot V, Tchernof A, Deshaies Y, Perusse L, Belisle A, Marceau S, et al. LINE-1 methylation in visceral adipose tissue of severely obese individuals is associated with metabolic syndrome status and related phenotypes. Clin Epigenetics. 2012;4:10.
Ehrlich M, Gama-Sosa MA, Huang LH, Midgett RM, Kuo KC, McCune RA, et al. Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells. Nucleic Acids Res. 1982;10:2709–21.
Baccarelli A, Wright R, Bollati V, Litonjua A, Zanobetti A, Tarantini L, et al. Ischemic heart disease and stroke in relation to blood DNA methylation. Epidemiology. 2010;21:819–28.
Luttmer R, Spijkerman AM, Kok RM, Jakobs C, Blom HJ, Serne EH, et al. Metabolic syndrome components are associated with DNA hypomethylation. Obes Res Clin Pract. 2013;7:e106–15.
Smolarek I, Wyszko E, Barciszewska AM, Nowak S, Gawronska I, Jablecka A, et al. Global DNA methylation changes in blood of patients with essential hypertension. Med Sci Monit. 2010;16:CR149–55.
Guay SP, Brisson D, Lamarche B, Biron S, Lescelleur O, Biertho L, et al. ADRB3gene promoter DNA methylation in blood and visceral adipose tissue is associated with metabolic disturbances in men. Epigenomics. 2014;6:33–43.
Peng P, Wang L, Yang X, Huang X, Ba Y, Chen X, et al. A preliminary study of the relationship between promoter methylation of the ABCG1, GALNT2 and HMGCR genes and coronary heart disease. PLoS ONE. 2014;9:1–8.
Mao SQ, Sun JH, Gu TL, Zhu FB, Yin FY, Zhang LN. Hypomethylation of interleukin-6 (IL-6) gene increases the risk of essential hypertension: a matched case-control study. J Hum Hypertens. 2017;31:530–6.
Macias-Gonzalez M, Martin-Nunez GM, Garrido-Sanchez L, Garcia-Fuentes E, Tinahones FJ, Morcillo S. Decreased blood pressure is related to changes in NF-kB promoter methylation levels after bariatric surgery. Surg Obes Relat Dis. 2018;14:1327–34.
Bao XJ, Mao SQ, Gu TL, Zheng SY, Zhao JS, Zhang LN. Hypomethylation of the Interferon gamma Gene as a Potential Risk Factor for Essential Hypertension: a Case–Control Study. Tohoku J Exp Med. 2018;244:283–90.
Rangel M, Dos Santos JC, Ortiz PHL, Hirata M, Jasiulionis MG, Araujo RC, et al. Modification of epigenetic patterns in low birth weight children: Importance of hypomethylation of the ACE gene promoter. PLoS ONE. 2014;9:1–8.
Fan R, Mao S, Zhong F, Gong M, Yin F, Hao L, et al. Association of AGTR1 promoter methylation levels with essential hypertension risk: a matched case–control study. Cytogenet Genome Res. 2015;147:95–102.
Lin J, Lin S, Wu Y, Wang X, Wu S, Li H. Hypomethylation of the Angiotensin II type I receptor (AGTR1) gene along with environmental factors increases the risk for essential hypertension. Cardiology. 2017;137:126–35.
Fan R, Wang WJ, Zhong QL, Duan SW, Xu XT, Hao LM, et al. Aberrant methylation of the GCK gene body is associated with the risk of essential hypertension. Mol Med Rep. 2015;12:2390–4.
Meng L, Chen D, Pei F, Hui R, Zheng Y, Chen J. DNA methylation in the norepinephrine transporter gene promoter region is not associated with depression and hypertension. Clin Exp Hypertens. 2017;39:539–45.
Mao S, Fan R, Gu T, Zhong Q, Gong M, Dong C, et al. Hypermethylation of SCNN1A gene-body increases the risk of essential hypertension. Int J Clin Exp Pathol. 2016;9:8047–56.
Zhang LN, Liu PP, Wang L, Yuan F, Xu L, Xin Y, et al. Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension. PLoS ONE. 2013;8:1–7.
Bayoumy NMK, El-Shabrawi MM, Leheta OF, Omar HH. alpha-Adducin gene promoter DNA methylation and the risk of essential hypertension. Clin Exp Hypertens. 2017;39:1–5.
Jin F, Li X, Wang Z, Liu Y, Liu J, Sun D, et al. Association of mitofusin 2 methylation and essential hypertension: a case-control study in a Chinese population. Hypertens Res. 2018;41:605–13.
Xu M, Li J, Chen X, Han L, Li L, Liu Y. MTHFD1 promoter hypermethylation increases the risk of hypertension. Clin Exp Hypertens. 2018;41:1–6.
Wang X, Falkner B, Zhu H, Shi H, Su S, Xu X, et al. A genome-wide methylation study on essential hypertension in young African American males. PLoS ONE. 2013;8:1–8.
Bostrom AE, Mwinyi J, Voisin S, Wu W, Schultes B, Zhang K, et al. Longitudinal genome-wide methylation study of Roux-en-Y gastric bypass patients reveals novel CpG sites associated with essential hypertension. BMC Med Genom. 2016;9:20.
Richard MA, Huan T, Ligthart S, Gondalia R, Jhun MA, Brody JA, et al. DNA methylation analysis identifies loci for blood pressure regulation. Am J Hum Genet. 2017;101:888–902.
Kresovich JK, Zhang Z, Fang F, Zheng Y, Sanchez-Guerra M, Joyce BT, et al. Histone 3 modifications and blood pressure in the Beijing Truck Driver Air Pollution Study. Biomarkers. 2017;22:584–93.
Gu Z, Wang H, Nekrutenko A. Li W-H. Densities, length proportions, and other distributional features of repetitive sequences in the human genome estimated from 430 megabases of genomic sequence. Gene. 2000;259:81–8.
Yang AS, Estécio MRH, Doshi K, Kondo Y, Tajara EH, Issa JPJ. A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements. Nucleic Acids Res. 2004;32:e38.
Su J, Shao X, Liu H, Liu S, Wu Q, Zhang Y. Genome-wide dynamic changes of DNA methylation of repetitive elements in human embryonic stem cells and fetal fibroblasts. Genomics. 2012;99:10–7.
Hopkins PN, Hunt SC. Genetics of hypertension. Genet Med. 2003;5:413–29.
Matsuoka Y, Li X, Bennett V. Adducin: structure, function and regulation. Cell Mol Life Sci. 2000;57:884–95.
Liao X, Wang W, Zeng Z, Yang Z, Dai H, Lei Y. Association of alpha-ADD1 gene and hypertension risk: a meta-analysis. Med Sci Monit. 2015;21:1634.
Ferrari P, Krozowski Z. Role of the 11beta-hydroxysteroid dehydrogenase type 2 in blood pressure regulation. Kidney Int. 2000;57:1374–81.
Mariniello B, Ronconi V, Sardu C, Pagliericcio A, Galletti F, Strazzullo P, et al. Analysis of the 11beta-hydroxysteroid dehydrogenase type 2 gene (HSD11B2) in human essential hypertension. Am J Hypertens. 2005;18:1091–8.
Huan T, Esko T, Peters MJ, Pilling LC, Schramm K, Schurmann C, et al. A meta-analysis of gene expression signatures of blood pressure and hypertension. PLoS Genet. 2015;11:e1005035.
Barfield RT, Almli LM, Kilaru V, Smith AK, Mercer KB, Duncan R, et al. Accounting for population stratification in DNA methylation studies. Genet Epidemiol. 2014;38:231–41.
Ligthart S, Marzi C, Aslibekyan S, Mendelson MM, Conneely KN, Tanaka T, et al. DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol. 2016;17:255.
Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet. 2011;12:529–41.
Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD. Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem. 2002;277:49175–85.
Schelwies M, Brinson D, Otsuki S, Hong YH, Lotz MK, Wong CH, et al. Glucosamine‐6‐sulfamate analogues of heparan sulfate as inhibitors of endosulfatases. ChemBioChem. 2010;11:2393–7.
Fyhrquist F, Metsärinne K, Tikkanen I. Role of angiotensin II in blood pressure regulation and in the pathophysiology of cardiovascular disorders. J Hum Hypertens. 1995;9:S19–24.
Lu Z, Tian Y, Salwen HR, Chlenski A, Godley LA, Raj JU, et al. Histone lysine methyltransferase EHMT2 is involved in proliferation, apoptosis, cell invasion, and DNA methylation of human neuroblastoma cells. Anticancer Drugs. 2013;24:484.
Shinkai Y, Tachibana M. H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev. 2011;25:781–8.
Minaki Y, Nakatani T, Mizuhara E, Inoue T, Ono Y. Identification of a novel transcriptional corepressor, Corl2, as a cerebellar Purkinje cell-selective marker. Gene Expr Patterns. 2008;8:418–23.
Bennett KL, Lee W, Lamarre E, Zhang X, Seth R, Scharpf J, et al. HPV status‐independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas. Genes Chromosomes Cancer. 2010;49:319–26.
Worgall TS. Sphingolipids: major regulators of lipid metabolism. Curr Opin Clin Nutr Metab Care. 2007;10:149–55.
Lewerenz J, Hewett SJ, Huang Y, Lambros M, Gout PW, Kalivas PW, et al. The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities. Antioxid Redox Signal. 2013;18:522–55.
Boks MP, Derks EM, Weisenberger DJ, Strengman E, Janson E, Sommer IE, et al. The relationship of DNA methylation with age, gender and genotype in twins and healthy controls. PLoS ONE. 2009;4:e6767.
Fuke C, Shimabukuro M, Petronis A, Sugimoto J, Oda T, Miura K, et al. Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet. 2004;68(Pt 3):196–204.
El-Maarri O, Becker T, Junen J, Manzoor SS, Diaz-Lacava A, Schwaab R, et al. Gender specific differences in levels of DNA methylation at selected loci from human total blood: a tendency toward higher methylation levels in males. Hum Genet. 2007;122:505–14.
Acknowledgements
The contributions of the authors were as follows: VG, EP, and MG screened title/abstract. VG obtained full text, determined eligibility of articles, and participated in data extraction. VG and EP assessed the quality of the included studies. EP participated in data synthesis/analysis and interpretation of the data. VG, EP, and JN drafted the final paper. All authors contributed to the critical revision of the paper and approved the final version.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Gonzalez-Jaramillo, V., Portilla-Fernandez, E., Glisic, M. et al. The role of DNA methylation and histone modifications in blood pressure: a systematic review. J Hum Hypertens 33, 703–715 (2019). https://doi.org/10.1038/s41371-019-0218-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41371-019-0218-7
This article is cited by
-
Integration of epigenetic regulatory mechanisms in heart failure
Basic Research in Cardiology (2023)
-
DNA methylation signature on phosphatidylethanol, not on self-reported alcohol consumption, predicts hazardous alcohol consumption in two distinct populations
Molecular Psychiatry (2021)
-
Epigenome association study for DNA methylation biomarkers in buccal and monocyte cells for female rheumatoid arthritis
Scientific Reports (2021)
-
DNA damage and expression of DNA methylation modulators in urine-derived cells of patients with hypertension and diabetes
Scientific Reports (2020)
-
Genetic and epigenetic analyses of panic disorder in the post-GWAS era
Journal of Neural Transmission (2020)